---

---

therapeutics   tags : Pharm-country   

save search

---

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
first drug authorized food depression treatment clearance for therapeutics

---

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PTCT | News S | $25.21 -0.79% -0.87% 560K |

Health Technology

| -6.32% | O: 2.01% H: 1.35% C: -0.18%
first conference therapeutics financial results

---

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
RLYB | News | $1.58 -9.2% -9.43% 250K |

| -4.24% | O: -3.03% H: 4.38% C: 1.87%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -2.12% | O: 0.21% H: 0.0% C: 0.0%
risk solutions for collaboration

---

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
TRVI | $2.65 -7.02% -6.34% 120K |

Health Technology

| -13.54% | O: 2.77% H: 1.59% C: -8.57%
conference presentation international therapeutics

---

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
Published: 2024-04-08 (Crawled : 12:00) - biospace.com/
BCLI A | $0.545 3.81% 1.67% 190K |

Health Technology

| -18.22% | O: -0.37% H: 0.0% C: 0.0%
update cell nurown program therapeutics

---

Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
RVMD | $35.59 -1.85% -1.97% 1.3M |

Health Technology

| 13.38% | O: 0.67% H: 1.8% C: -4.62%
antibody collaboration therapeutics

---

Traws Pharma Announces New Employee Inducement Grants - April 02, 2024
Published: 2024-04-02 (Crawled : 13:00) - biospace.com/
ONTX | $0.9953 -5.61% 1.3M |

Health Technology

| Email alert Add to watchlist
pharma grants employee

---

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.17 -1.68% 1.2% 17K |

Health Technology

| -21.48% | O: 5.37% H: 0.64% C: -12.1%
obesity treatment wholly

---

Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
CNTX | $1.3 -7.8% -2.17% 37K |

Health Technology

| 13.04% | O: 0.87% H: 6.78% C: -7.76%
year therapeutics financial results

---

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M |

Health Technology

| -6.65% | O: 0.46% H: 0.23% C: -1.88%
acquisition

---

Merck Completes Acquisition of Harpoon Therapeutics, Inc.
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
MRK | $127.0 0.1% 0.63% 5.7M |

Health Technology

| 2.83% | O: 0.93% H: 0.0% C: -1.51%
merck acquisition

---

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
LXEO | News | $12.5 2.97% 2.45% 99K |

| -17.38% | O: 6.87% H: 0.0% C: -10.39%
year therapeutics financial results

---

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024MiNK-215 Eradicated Tumor Cells in Human Organoid MSS Colorectal Cancer Liver Metastases Model
Published: 2024-03-06 (Crawled : 14:00) - biospace.com/
INKT | $0.889 2.07% 0.11% 39K |

| -9.18% | O: 1.02% H: 0.48% C: -1.41%
nk-215 liver cancer tumor preclinical

---

AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 0.95% | O: 1.17% H: 0.0% C: 0.0%
lung drug cancer treatment application therapeutics

---

Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
HOTH | $1.17 -1.68% 1.2% 17K |

Health Technology

| -10.0% | O: -2.31% H: 4.72% C: -3.15%
patent therapeutics

---

VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
VYNE | $2.57 10.78% 12.45% 380K |

Health Technology

| 9.36% | O: -0.43% H: 1.71% C: 1.28%
vyn201 symposium global trial therapeutics results

---

TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)Newly issued patents extend exclusivity of ublituximab through 2042
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
TGTX | $13.98 -1.9% -1.86% 2.4M |

Health Technology

| 4.64% | O: 3.44% H: 1.77% C: 0.65%
briumvi therapeutics

---

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
NRXP 5 d | $3.12 2.3% 1.93% 98K |

Manufacturing

| 609.09% | O: 6.89% H: 0.81% C: -9.08%
ceo conference hope pharmaceuticals

---

SpringWorks Therapeutics to Present at Upcoming Investor Conferences - February 22, 2024
Published: 2024-02-22 (Crawled : 17:00) - biospace.com/
SWTX | $43.38 -1.41% -1.45% 500K |

Health Technology

| -11.87% | O: -1.75% H: 3.4% C: 1.55%
therapeutics

---

NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NRXP 5 d | $3.12 2.3% 1.93% 98K |

Manufacturing

| 562.7% | O: -0.45% H: 5.36% C: -4.01%
ceo conference hope pharmaceuticals

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---